We further compared mutational signatures occurring in the CHEK2-deficient cancers to those in a cohort of (mostly) sporadic cancers (n = 7515) from TCGA of various tissue origins (Supplementary Figure 4, available online). The gene discussed is CHEK2; the disease is cancer.